lipoxin a4 has been researched along with Angiogenesis, Pathologic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, HEP; Do, KV; He, J; Kakazu, AH; Pham, TL; Ponnath, A | 1 |
| Marginean, A; Sharma-Walia, N | 1 |
| Janecka, A; Zubrzycka, A; Zubrzycka, M; Zubrzycki, M | 1 |
| Bruni, F; Carvalho, RR; Felisbino, SL; Hiruma-Lima, CA; Justulin, L; Lopes-Ferreira, M; Pellizzon, CH; Vilegas, W | 1 |
| Baker, N; Godson, C; Maderna, P; O'Meara, SJ; Scannell, M | 1 |
| Dong, B; Gronert, K; Lau, D; Leedom, AJ; Sullivan, AB | 1 |
| Cai, L; Chen, X; Chen, Y; Hao, H; He, S; Hoidal, J; Hu, S; Li, Y; Wu, P; Ye, D | 1 |
| Cai, L; Chen, Y; Hao, H; Li, Y; Liu, M; Tang, K; Wu, P; Ye, D; Yi, P | 1 |
| Das, UN | 1 |
| Cezar-de-Mello, PF; Fierro, IM; Nascimento-Silva, V; Villela, CG | 1 |
| Barja-Fidalgo, C; Cezar-de-Mello, PF; Fierro, IM; Nascimento-Silva, V; Vieira, AM; Villela, CG | 1 |
| Fierro, IM; Kutok, JL; Serhan, CN | 1 |
2 review(s) available for lipoxin a4 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
New Horizons in the Etiopathogenesis and Non-Invasive Diagnosis of Endometriosis.
Topics: Animals; Biomarkers; Endocannabinoids; Endometriosis; Estrogens; Female; Genetic Predisposition to Disease; Humans; Iron; Lipoxins; MicroRNAs; Neovascularization, Pathologic; Neurogenesis; Oxidative Stress; Risk Factors; Stem Cells; Telomerase | 2015 |
Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy.
Topics: Antibodies, Monoclonal; Cytokines; Diabetic Retinopathy; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Inflammation Mediators; Interleukin-6; Lipoxins; Macular Edema; Neovascularization, Pathologic; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2013 |
10 other study(ies) available for lipoxin a4 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome.
Topics: Alkalies; Animals; Burns, Chemical; Corneal Opacity; Cytokines; Hyphema; Inflammation; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Transcriptome; Vascular Endothelial Growth Factor A | 2023 |
Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cyclooxygenase 2; Down-Regulation; Endothelial Cells; Humans; Inflammation Mediators; Lipoxins; Models, Biological; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Receptors, Lipoxin; Sarcoma, Kaposi; Transcription Factors; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Effect of mangiferin on the development of periodontal disease: involvement of lipoxin A4, anti-chemotaxic action in leukocyte rolling.
Topics: Alveolar Bone Loss; Animals; Cell Adhesion; Cell Proliferation; Cyclooxygenase 2; Disease Models, Animal; Drug Evaluation, Preclinical; Leukocyte Rolling; Lipoxins; Male; Neovascularization, Pathologic; Periodontitis; Piroxicam; Rats; Rats, Wistar; Xanthones | 2009 |
Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells.
Topics: Angiogenesis Inhibitors; Cell Proliferation; Cells, Cultured; Coculture Techniques; Cytokines; Endothelium, Vascular; Humans; Inflammation Mediators; Leukotriene D4; Lipoxins; Neovascularization, Pathologic; Phosphorylation; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.
Topics: Administration, Topical; Animals; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Autacoids; Cornea; Corneal Diseases; Down-Regulation; Gene Deletion; Inflammation; Lipoxins; Metabolic Networks and Pathways; Mice; Neovascularization, Pathologic; Phenotype | 2010 |
Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Drug Screening Assays, Antitumor; Heptanoic Acids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipoxins; Mice; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A | 2010 |
Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Heptanoic Acids; Humans; Lipoxins; Liver Neoplasms; Macrophages; Male; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Tumor Microenvironment | 2011 |
Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly.
Topics: Actins; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Adhesion; Cell Movement; Cells, Cultured; Cytoskeleton; Endothelium, Vascular; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Lipoxins; Mitogen-Activated Protein Kinase 11; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Time Factors; Vascular Endothelial Growth Factor A | 2006 |
ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor.
Topics: Active Transport, Cell Nucleus; Cell Adhesion; Cell Proliferation; Gene Expression Regulation; Humans; Lipoxins; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Umbilical Veins; Vascular Endothelial Growth Factor A | 2008 |
Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cell Movement; Cells, Cultured; Chemotaxis; DNA Fragmentation; Eicosanoids; Endothelial Growth Factors; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Immunohistochemistry; Leukotriene A4; Lipid Metabolism; Lipoxins; Lymphokines; Microscopy, Fluorescence; Neovascularization, Pathologic; Umbilical Cord; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |